[25-014155] NIH nhlbi DNA sequencing core requires needs reagents/kits in order to to run miseq, novaseqx plus, iseq, and NEXTSEQ1000.
Ended Awarded Last action
- Contract number
- 75N92025F00019
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $248,211
Award facts
- Contract value 100% obligated
- $248,210.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92122, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $248,211 |
About this award
The National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health, awarded a delivery order valued at $248,210.70 to Illumina, Inc. for DNA sequencing reagents and kits required to operate the organization's genomic analysis instrumentation. Specifically, the contract supplies consumables and reagent kits compatible with Illumina's MiSeq, NovaSeqX Plus, iSeq, and NextSeq 1000 sequencing platforms. The award utilizes firm fixed pricing with no set-aside designation, reflecting Illumina's specialized capabilities as the sole provider of compatible sequencing reagents for these instruments. Performance will take place at the NHLBI's facility in San Diego, California, with an ultimate completion date of February 19, 2026.
This delivery order represents a continuation of the NHLBI's genomic sequencing capabilities supporting the institute's research mission in cardiovascular, pulmonary, and blood disorders. Illumina, headquartered in San Diego, is a leading biotechnology company that manufactures advanced DNA and RNA sequencing instruments, reagents, and bioinformatics software. The company maintains an extensive contracting relationship across multiple federal agencies, including the NIH, Centers for Disease Control and Prevention, and Department of Agriculture, providing critical genomic sequencing platforms and consumables for research, diagnostics, and public health applications.
Quick answers
Who was awarded contract 75N92025F00019?
75N92025F00019 was awarded to Illumina, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on August 19, 2025.
How much is contract 75N92025F00019 worth?
The government has obligated $248,211 on 75N92025F00019.
Is contract 75N92025F00019 an order under another contract?
Yes. 75N92025F00019 is a delivery order under 75N92020D00022, an indefinite delivery contract.
Was contract 75N92025F00019 competed?
The extent of competition for 75N92025F00019 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award